Rishi Pukhraj, Rishi Ekta, Attiku Yamini, Uparkar Mahesh, Bhende Pramod, Bhende Muna, Sen Parveen
Shri Bhagwan Mahavir Vitreo-Retinal Services, Sankara Nethralaya, Medical Research Foundation, Chennai, Tamilnadu, India.
J Vitreoretin Dis. 2020 Jul 3;4(6):467-471. doi: 10.1177/2474126420930504. eCollection 2020 Nov-Dec.
This work studies outcomes of external subretinal fluid (SRF) drainage in management of eyes with advanced Coats disease.
Patients with advanced-stage Coats disease (≥stage 3B), who were younger than 12 years and underwent external SRF drainage from 1996 to 2016, were included in this retrospective study. Surgical intervention involved external drainage of SRF and cryotherapy. SRF drainage was performed by lamellar scleral dissection or by external needle drainage. Favorable anatomical outcome was defined as retinal reattachment with normal intraocular pressure (IOP). IOP greater than 24 mm Hg was considered raised. Univariate and multivariate analyses were performed to measure the association between preoperative or intraoperative factors and retinal status at final follow-up. Outcome measures evaluated included visual acuity, IOP, retinal status, globe status, and complications of surgery. Kaplan-Meier analysis was performed for globe salvage without pain.
Thirty-two eyes of 32 patients were included in the study. Mean age at surgery was 3.8 ± 3 years. The mean duration of follow-up was 7 years (range, 6 months-15.7 years). Improvement in visual acuity was seen in 5 eyes. Retina was attached at final visit in 6 eyes. IOP in the range of 8 to 24 mm Hg was noted in 16 eyes. Favorable anatomical outcome was achieved in 3 (9%) eyes. Globe salvage was achieved in 84% of eyes. Complications included intraoperative vitreous hemorrhage (n = 1) and postoperative inflammation (n = 1). Kaplan-Meier ocular survival rate without pain at 10 years was 76%.
SRF drainage and cryotherapy in eyes with advanced Coats disease favorably alter the natural history of the disease and prevent end-stage complications. Visual outcomes remain poor.
本研究探讨外路视网膜下液(SRF)引流术治疗晚期Coats病的疗效。
本回顾性研究纳入1996年至2016年间接受外路SRF引流术、年龄小于12岁的晚期Coats病(≥3B期)患者。手术干预包括SRF外引流术和冷冻疗法。SRF引流通过板层巩膜切开术或外路针吸引流进行。良好的解剖学结局定义为视网膜复位且眼压(IOP)正常。IOP大于24 mmHg被视为眼压升高。进行单因素和多因素分析以衡量术前或术中因素与最终随访时视网膜状态之间的关联。评估的结局指标包括视力、IOP、视网膜状态、眼球状态和手术并发症。对无痛性眼球挽救进行Kaplan-Meier分析。
32例患者的32只眼纳入研究。手术时的平均年龄为3.8±3岁。平均随访时间为7年(范围6个月至15.7年)。5只眼视力改善。6只眼在末次随访时视网膜复位。16只眼的IOP在8至24 mmHg范围内。3只眼(9%)获得良好的解剖学结局。84%的眼球实现了眼球挽救。并发症包括术中玻璃体出血(n = 1)和术后炎症(n = 1)。10年时无痛性眼球生存率的Kaplan-Meier分析结果为76%。
晚期Coats病患者行SRF引流术和冷冻疗法可改善疾病的自然病程并预防终末期并发症。视力预后仍然较差。